Onconic Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	47,046	43,000	30,100	27,316	18,861
Trading Asset Securities	5,689	-	-	-	-
Cash & Short-Term Investments	52,735	43,000	30,100	27,316	18,861
Cash Growth	22.64%	42.85%	10.19%	44.83%	-
Accounts Receivable	10,531	7,326	150.69	841.52	173.71
Other Receivables	46.21	254.84	315.69	5.08	2.9
Receivables	10,578	7,581	466.37	846.6	176.61
Prepaid Expenses	47.24	-	-	-	-
Other Current Assets	476.7	1,554	192.22	8.22	10.43
Total Current Assets	63,837	52,134	30,759	28,171	19,048
Property, Plant & Equipment	3,060	3,285	3,568	2,619	263.6
Other Intangible Assets	0.1	1.27	2.45	3.63	4.8
Long-Term Deferred Tax Assets	8,800	5,355	3,100	-	-
Other Long-Term Assets	9.25	137.95	118.38	113.14	110.6
Total Assets	75,707	60,913	37,548	30,907	19,427
Accounts Payable	2,669	708.67	-	-	-
Accrued Expenses	75.51	65.56	82.14	-	-
Current Portion of Long-Term Debt	-	-	13,795	-	-
Current Portion of Leases	81.27	188.95	154.27	50.72	135.52
Current Income Taxes Payable	22.39	463.39	-	-	-
Other Current Liabilities	774.07	3,339	42,977	26,539	392.14
Total Current Liabilities	3,623	4,765	57,009	26,590	527.66
Long-Term Leases	44.53	119.52	199.4	-	53.52
Pension & Post-Retirement Benefits	-	9.59	3.8	25.04	-
Other Long-Term Liabilities	-	0	25.14	26,229	26,823
Total Liabilities	3,667	4,895	57,237	52,844	27,405
Common Stock	22,245	5,402	2,890	2,890	2,890
Additional Paid-In Capital	22,576	87,419	7,146	7,146	7,146
Retained Earnings	26,682	-39,121	-31,019	-32,688	-18,256
Comprehensive Income & Other	536.94	2,319	1,294	715.69	243.21
Shareholders' Equity	72,039	56,019	-19,690	-21,937	-7,978
Total Liabilities & Equity	75,707	60,913	37,548	30,907	19,427
Total Debt	125.8	308.47	14,149	50.72	189.04
Net Cash (Debt)	52,609	42,691	15,951	27,265	18,672
Net Cash Growth	23.23%	167.63%	-41.50%	46.02%	-
Net Cash Per Share	-	1305.39	689.98	1179.32	815.23
Filing Date Shares Outstanding	-	43.22	36.83	23.12	22.9
Total Common Shares Outstanding	-	43.22	36.83	23.12	22.9
Working Capital	60,214	47,369	-26,250	1,581	18,520
Book Value Per Share	-	1296.26	-534.61	-948.83	-348.30
Tangible Book Value	72,039	56,018	-19,692	-21,941	-7,982
Tangible Book Value Per Share	-	1296.23	-534.68	-948.99	-348.51
Land	570.58	570.58	-	-	-
Buildings	1,617	1,617	-	-	-
Machinery	1,495	1,138	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.